Home › Forums › Main Forum › Media & News › Research and Trials › Phase II/III STORM-C-1 trial results from EASL 2018
Brief article outlining the Phase II/III STORM-C-1 trial presented by the non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) at the International Liver Conference in Paris
https://medicalxpress.com/news/2018-04-hepatitis-combination-treatment.html